In vitro exposures to air pollutants could, in theory, facilitate a rapid and detailed assessment of molecular mechanisms of toxicity. However, it is difficult to ensure that the dose of a gaseous pollutant to cells in tissue culture is similar to that of the same cells during in vivo exposure of a living person. The goal of the present study was to compare the dose and effect of O 3 in airway cells of humans exposed in vivo to that of human cells exposed in vitro. Ten subjects breathed labeled O 3 ( 18 O 3 , 0.3 ppm, 2 h) while exercising intermittently. Bronchial brush biopsies and lung lavage fluids were collected 1 h post exposure for in vivo data whereas in vitro data were obtained from primary cultures of human bronchial epithelial cells exposed to 0.25-1.0 ppm 18 O 3 for 2 h. The O 3 dose to the cells was defined as the level of 18 O incorporation and the O 3 effect as the fold increase in expression of inflammatory marker genes (IL-8 and COX-2). Dose and effect in cells removed from in vivo exposed subjects were lower than in cells exposed to the same 18 O 3 concentration in vitro suggesting upper airway O 3 scrubbing in vivo. Cells collected by lavage as well as previous studies in monkeys show that cells deeper in the lung receive a higher O 3 dose than cells in the bronchus. We conclude that the methods used herein show promise for replicating and comparing the in vivo dose and effect of O 3 in an in vitro system.
vitro cell cultures to in vivo human bronchial epithelial cells. Epithelial cells were chosen because they secrete mediators which initiate inflammatory events that are believed to be important in human risk assessments. They also can be expanded in airliquid interface cultures and used in high throughput assays. Ozone (O 3 ) was chosen as a prototype pollutant because it is one of the best-studied and ubiquitous of pure gaseous inhalants (U. S. E. P. A., 2013) .
We showed previously that exposure to heavy oxygenlabeled ozone ( 18 O 3 ) results in incorporation of 18 O into cells and extracellular material obtained from bronchoalveolar lavage fluid (BALF) of humans and animals (Hatch et al., 1994 (Hatch et al., , 2013 Plopper et al., 1998 ) creating a convenient micro-measurement of O 3 dose that is related to O 3 toxicity. We have also demonstrated that epithelial cells release mediators following O 3 exposure that are early markers of inflammation and that appear to have health consequences in the human population (Devlin et al., 1996; Devlin et al., 2012) . The generation of these mediators can be quantified by gene expression assays. We here compare the 18 O 3 dose and gene expression of two inflammatory mediators in cells obtained from human subjects exposed in vivo with the same measurements made in human primary cells expanded in culture and exposed in an air-liquid interface system in vitro.
MATERIALS AND METHODS
A flow chart depicting the study design is shown in Figure 1 . In vivo exposures to 18 O 3 (for dose measurement) and unlabeled O 3 for gene expression measurement were compared with in vitro exposures of the same length (2 h) that measured the same dose and effect endpoints. In vitro exposures to 18 O 3 were performed on cells expanded from two subjects, and gene expression changes were evaluated in cells expanded from three subjects. Both the dose and effect in vitro studies employed the same range of 18 O 3 or unlabeled O 3 concentrations. Cells were harvested at the termination of exposure in both the in vivo and in vitro studies.
In Vivo 18 O 3 Exposures of Human Subjects
For the dosimetry of ten subjects, eight (seven Caucasian and one Hispanic) were male and two (one Caucasian and one Hispanic) were female, and the following data apply: age 26 ± 1 years (19-33 years), body weight 80.8 ± 2.8 kg, height 176.9 ± 3.0 cm, and resting forced vital capacity (FVC) 5.55 ± 0.27 l. For the biological effects study of nine subjects, all were males (one Black, one Hispanic and seven Caucasian), with the following characteristics: age 23.7 ± 0.9 (20-29 years), body weight 86.1 ± 2.6 kg, height 182.0 ± 2.0 cm, and resting FVC 5.88 ± 0.2 l. The study protocol was approved by the University of North Carolina Committee on the Rights of Human Subjects (Institutional Review Board) as well as the U.S. Environmental Protection Agency. All individuals provided written informed consent and were recruited under a contract to the Westat Corp. (Rockville, MD). All subjects underwent a physical examination, with a complete blood count and differential, serum electrolytes, glucose, and liver enzymes. Female subjects had a negative urine pregnancy test. Volunteers were excluded from the study if they had a smoking history within 2 years of the study, or were not able to refrain from taking over-the-counter anti-inflammatory agents, vitamins, or antioxidants for at least a week prior to exposure. Participants who reported a recent respiratory tract infection (or who had symptoms) were not studied for a period of at least 6 weeks after symptoms had disappeared. Each volunteer was exposed on a single occasion for 2 h to 18 O 3 . Subjects were seated on a bicycle ergometer with their forehead touching a pad on the top of a 6 inch diameter cone that blew 18 O 3 downward across the face at a flow rate of 500 l/min.
The ozone concentration delivered did not deviate from the target concentration by more than ±5%. A sampling tube (with a flow rate of 2-2.5 l/min) similar to a head-mounted microphone collected breathing air 1-2 inches in front of the face of the subject. 18 O 3 concentrations were thus monitored in the breathing zone every 10 s and stored as 2 min averages. Mean concentrations in the breathing zone ranged from 0.21 to 0.33 ppm and were 30-50% lower than in the incoming airstream. Throughout the exposure, volunteers underwent moderate intermittent exercise (15 min intervals) on the bicycle ergometer. The level of exercise was targeted to a minute ventilation (V e ) of 25 l/min/m 2 body surface area (∼50 l/min/subject). Prior to the exposure day, all subjects participated in a training session to establish the workload that would be required to achieve this V e and the same work load was targeted on the ergometer. Subjects breathed naturally by mouth or nose depending on the subjects' comfort level. On the study day, all subjects performed a pulmonary function test prior to the exposure using a Sensormedics Vmax 220 instrument and software (Sensormedics Corp., Yorba Linda, CA) according to American Thoracic Society guidelines. Spirometry was also conducted on all subjects immediately following the exposure. Decrements in FEV 1 were Ͻ20% for all subjects post-versus pre-exposure. All volunteers had forced expiratory volume in 1 s (FEV 1 ) and FVC baseline values of at least 80% of that predicted for their height, age, and gender. Subjects were outfitted with a telemetry unit for the duration of the 18 O 3 exposure and bronchoscopy for continuous monitoring of heart rate and rhythm as well as finger oxidimetry for O 2 saturation. Each subject was exposed twice, once to air and once to O 3 , separated by at least 2 weeks.
In vivo 18 Bronchoscopic sample collection. A bronchoscopy was conducted ∼45 min following the completion of the 2 h exposure to 18 O 3 as described previously (Ghio et al., 1998) modified as follows. Immediately prior to the procedure, subjects were given intravenous fluids through a saline lock catheter placed in an antecubital vein to ensure they were hydrated. Primary bronchial epithelial cells were obtained by brush biopsy of both the right and left mainstem bronchus. Each bronchus was brushed six times in and out with a ∼5 cm excursion, and then repeated with a second brush. The two cytology brushes from each side were kept separate and the epithelial cells dislodged by agitation and brief vortexing in 0.1 ml of cold Dulbecco's phosphate buffered saline. The dislodged cells were pelleted by centrifugation at 400 × g at 4 • C. For 18 O measurements, the supernatant was removed and the remaining cell pellet was lysed by pipetting up and down in 0.1 ml of 0.05% SDS. This solution was then diluted by adding an additional 0.1 ml of water. Bronchoalveolar lavage was conducted after the collection of the brush biopsies. Three 50 ml aliquots of sterile saline were sequentially injected into the right middle lung lobe. After each aliquot of saline was instilled it was gently aspirated back into the same syringe. The unfiltered lavage fluid was placed on ice in 50 ml conical tubes. Mean percent recovery volumes (range) of BALF from each lavage were as follows: wash no. 1; 29.4 ± 7.0% (14-38%), wash no. 2; 67.4 ± 9.2% (52-84%), wash no. 3; 77.8 ± 11.4% (58-92%). Samples were immediately centrifuged at 1000 × g for 10 min at 4
• C to pellet the cell fraction. BALF supernatants from all three aliquots were pooled and stored at −80
• C for subsequent analysis of 18 incorporation is 142,000-to 210,000-fold higher on a per ppm basis (Supplementary table 1) . This difference in incorporation appears to be the result of higher chemical reactivity of the 18 O 3 and is evident even though the incorporation of 18 O 2 into cells also includes uptake resulting from normal metabolic processes.
Tissue and BALF Fraction Preparation for 18 O Analysis
BALF cell pellets were resuspended in 0.2 ml of 0.025% SDS. BALF supernatants were combined and centrifuged for 1 h at 22,000 × g to obtain a white "surfactant pellet." The resulting dried supernatant contained proteins and lipids mixed in a high NaCl matrix that could interfere with measurement of 18 O. For this reason, we precipitated the protein by adding trichloroacetic acid (TCA) to a final concentration of 10% and centrifuged again (40,000 × g for 1 h at 4 • C). The surfactant and TCA pellets were resuspended in 0.4 ml of the 0.025% SDS solution.
Immediately following the in vitro exposures, cells were analyzed for 18 O content. This time point was chosen to minimize metabolism of the 18 O signal by cells and to coincide with the same time point in which ozone-induced changes in mRNAs coding for pro-inflammatory proteins have been observed. Cells were lysed by the addition of 0.1 ml of 0.05% SDS to the api-cal surface. The cells were dislodged from the filter support using a pipette tip and the lysate transferred to a cryovial. The filter support was rinsed with an additional 0.1 ml of water and this was pooled with the original 0. Analysis of 18 O in lyophilized samples has been described previously (Hatch et al., 1994; Santrock et al., 1989) . Briefly, lyophilized samples weighing 0.5-1.5 mg were placed into silver cups (3 × 5 mm), crimped, and then placed into an elemental analyzer (Carlo Erba Instruments, Italy) where all oxygen in the samples was converted to CO under a stream of pure helium. The elemental analyzer quantified the CO which yielded a percentage (per dry weight) of total elemental oxygen in each sample. The helium/CO effluent of the elemental analyzer was captured and passed by continuous flow through a heated (110
column of granular I 2 O 5 (to convert CO to CO 2 ), then a cryogenic trap (−60 • C to remove produced I 2 ), and then bled by capillary into the vacuum of an isotope ratio mass spectrometer (SIRA 10, VG instruments) where the ratios between CO 2 masses were determined. 18 O 3 exposed samples were compared with their natural abundance controls inserted into each run.
Quantitative RT-PCR for Detection of Gene Expression Changes
Gene expression changes of the inflammatory markers IL-8 and COX-2 in human airway epithelial cells were quantified using reverse transcription polymerase chain reaction (RT-PCR). Total RNA was isolated using an RNeasy Mini Kit according to manufacturer's instructions (Qiagen, Valencia, CA). RNA quantity was determined on a Nanodrop ND-1000 and RNA integrity was assessed using RNA6000 Nano chips on a Bioanalyzer 2100 (Agilent). Total RNA (100-200 ng) was reverse transcribed to generate cDNA using the High Capacity cDNA Reverse Transcription kit (Life Technologies Applied Biosystems, Foster City, CA). Quantitative fluorogenic amplification of cDNA was performed using the ABI StepOnePlusTM Real-Time PCR System (Applied Biosystems) with iTaq Universal Probes Supermix (BioRad), primer/probe sets for the target gene of interest multiplexed with b-actin (ACTB) primer/probe sets as the normalizing housekeeping gene (20× VIC/MGB, Primer Limited, Applied Biosystems). Values from triplicate technical replicates for each sample were averaged and data analyzed using the DDCt method to obtain fold change values following ozone exposure with respect to air exposure values.
Data Analysis
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RESULTS

Methodology Findings
The cells obtained by brush biopsy were estimated to be greater than 95% epithelial cells. We originally explored trying to determine the percentage of different types of epithelial cells in the biopsies but they come off the brush in clumps making this impossible. The only cells that grow from these biopsies are the basal cells. Ciliated cells, mucus cells, clara cells, etc. are all terminally differentiated and do not divide in culture. Cell counts and differentials obtained from BALF are shown in Supplementary table 2. Percentage of polymorphonuclear leukocytes (PMNs) was increased by O 3 exposure at both the 1 h and 24 h BALF collection times.
We were able to obtain sufficient sample from a single culture well of confluent epithelial cells, or from the brush biopsy from one main bronchus. BALF cells and surfactant pellets yielded larger samples than were obtained from TCA pellets of BALF. Our 18 O analysis required 0.5-1.5 mg of dry weight with a total oxygen percentage Ͼ10%. The bronchial biopsies barely met these requirements and for this reason the gene expression changes could not have been measured in the same samples as the 18 O dose. The detection limit for the 18 O assay depends on (1) the quantity of elemental oxygen in the sample (accuracy improves with higher oxygen/sample) and (2) number of replicate samples (accuracy improves with higher number of samples analyzed due to both "memory" from the previous samples and increased statistical power with larger sample numbers). Dry weights of brush biopsy samples are shown in Supplementary table 3. The 18 O values for the left and right bronchial brush biopsies were averaged because there was no correlation between the two measurements. The use of SDS for lysis and dispersion of samples prevented sticking of dry sample to the walls of the tubes that facilitated weighing the samples into silver sampling cups after lyophilization. The contribution of SDS to the dry weight of the samples was ∼10% for the BALF cell and surfactant fractions, and 5% for the other samples.
Elemental Oxygen Percentages
Oxygen percentages that were used in converting the units of 18 O dose as described above were as follows (mean ± SE): in vitro epithelial cells expt. 1, 17.0 ± 0.7; in vitro epithelial cells expt. 2, 17.2 ± 1.2; in vivo bronchial brush biopsies, 12.7 ± 0.9; BALF cells, 16.2 ± 1.1; BALF supernatant TCA pellet, 11.9 ± 0.8; BALF surfactant pellet, 18.0 ± 0.2; plasma 1, 23.8 ± 1.7; Plasma 2, 21.4 ± 1.1. Figure 3 shows the fold increases (±SE) in gene expression of IL-8 and COX-2 in bronchial brush biopsies from in vivo O 3 exposures and primary epithelial cell cultures exposed in vitro to the same range of O 3 concentrations as was used for the 18 O 3 study.
Comparison of In Vitro and In
Comparison of In Vitro and In Vivo O 3 Biological Effects
Similar to the 18 O data, the in vivo gene expression was lower than that observed following in vitro exposure. The IL-8 increase in expression in the in vivo exposed cells fell about 30% below that observed in vitro and the in vivo COX-2 response fell about 17% below the response observed in vitro. The in vitro expression of IL-8 was higher than the expression of COX-2 but both genes were induced in a concentration-related manner that leveled off at 0.75 and 1.0 ppm O 3 . Although epithelial cells obtained from subjects exposed in vivo showed elevations in gene expression smaller than were observed at the lowest dose (0.25 ppm) used in the in vitro study, the increases in both genes were significant by paired t-test of the nine subjects studied. 18 O incorporation measured after in vivo exposure to 18 O 3 resulted in higher 18 O incorporation into cell and surfactant frac- Figure 2 . Shown are the fold increases in expression of IL-8 or COX-2 genes (means ± SE) in bronchial brush biopsies obtained from nine human subjects exposed in vivo to O3 compared with their response following exposure to clean air. Also shown are fold increases of primary epithelial cells exposed in vitro to each O3 concentration (means ± SE for three subjects and three replicates per subject) compared with their response following exposure to clean air. Asterisks denote significance (p Ͻ 0.05). Fig. 2 ) and BALF constituents of the same subjects following exposure to 18 O3 (0.3 ppm, 2 h with intermittent exercise). Means ± SE are shown for 10 subjects. All 18 O3
Comparison of 18 O in Bronchial Brush Biopsies to Three BALF Fractions
FIG. 4. Comparison of 18 O incorporation into epithelial cells (shown in
exposed tissues had significantly elevated 18 O when compared with the natural abundance 18 O concentration of blood plasma.
tions of BALF than bronchial brush biopsies from the same subjects (Fig. 4) . The BALF surfactant incorporated the highest levels of 18 O, which had a mean value slightly higher than the BALF cells, fourfold higher than BALF TCA pellet, and about eightfold higher than the mean of the left and right bronchial brush biopsies. A subject-by-subject plot of the relationship between the four tissue pools is shown in Supplementary figure 1. 
DISCUSSION
We achieved a proof-of-concept for obtaining comparable measurements of O 3 dose and effect between in vivo exposed epithelial cells and in vitro exposed primary epithelial cells exposed in an air-liquid interface culture. Prior to this, few, if any, equivalent measurements for an air pollutant gas had been identified and compared under both in vivo and in vitro conditions. Problems have included finding equivalent denominators applicable to both types of exposure. For example, measurements of released cytokines or LDH depend on equivalent volumes of extracellular fluid that cannot be controlled equally under in vivo and in vitro conditions. Although the main goal of the study was to compare the dose and response in epithelial cells, some valuable insights were obtained about the relative O 3 dose in different cell types. Epithelial cell production of inflammatory mediators appears to be easily measured by gene expression assays, and primary human epithelial cells appear to be a good model that could be expanded in air-liquid interface cultures used in high throughput assays. This is the first report of 18 O incorporation into human bronchial epithelial cells in vivo or into any type of cell exposed to 18 O 3 in vitro. Our previous studies examined BALF constituents of humans and rats exposed in vivo to 18 O 3 but did not include epithelial cells (Hatch et al., 1994) . It was interesting that both the O 3 dose and effect observed in vivo always fell below that observed in the in vitro exposures at the same air concentration of O 3 . Previous studies that measured O 3 air concentrations in the posterior pharynx of exercising human subjects found that fractional removal of O 3 in the nose is ∼40% (Gerrity et al., 1994 It is likely that the bronchial brush biopsy samples measured here gave a low approximation of epithelial cell dose compared with the distal airways that appear to be the main targets for O 3 in the human lung. A prior study of resting Rhesus monkeys showed that in vivo exposure (0.4 or 1.0 ppm 18 O 3 for 2 h) resulted in bronchial cell levels of 18 O similar to those observed here for bronchial cells of exercising humans (Plopper et al., 1998) : the bronchial cells of monkeys incorporated 4-7 ug 18 O/g dry while the human bronchial cells incorporated ∼10 ug 18 O/g dry. The smallest airways of the monkey (respiratory bronchioles) had a 2-4-fold higher 18 O incorporation than cells of the main bronchus suggesting that human terminal airways would be higher as well. This higher dose deeper in the lung is supported by the 4-8-fold higher 18 O incorporation observed here in the BALF constituents. Histopathology data on O 3 injury to epithelium and O 3 dosimetry uptake models also predict the highest O 3 dose and effect in the small terminal airways of all species (Barry et al., 1985; Miller et al, 1978 ). It would not be possible to biopsy tissues of these small airways in human subjects. The above-mentioned references also demonstrate that although we examined only one dose of 18 O 3 in the present in vivo study, a dose response behavior should be expected. Taken together, our results suggest that the dose response we observed here in the in vitro exposed epithelial cells covered a reasonable range of doses for human airway epithelial cells exposed in vivo. In addition to the epithelial cell data, we learned that BALF constituents experience a high dose of 18 O 3 compared with bronchial epithelial cells. This difference might be due to the larger surface area exposed or biochemical differences in reactivity of the 18 O 3 . We have observed in other studies that low ascorbate is related to high 18 O 3 levels in BALF (Gunnison and Hatch, 1999; Kari et al., 1997) . The lack of ascorbate in the culture media used here would have resulted in a loss of ascorbate from cells during culture (Lane et al., 2013) which would have increased the incorporation of 18 O 3 in in vitro cells compared with the cells exposed in vivo that are known to be bathed in extracellular ascorbate (Slade et al., 1993; van der Vliet et al., 1999) . In an earlier study, we reported a 30-50% lower 18 O incorporation into human BALF cells and surfactant pellets than we observed here. This was in spite of the fact that the earlier study involved a higher 18 O 3 concentration (0.4 ppm, 2 h rather than 0.3 ppm, 2 h) and higher targeted minute ventilation (60 l/min/subject vs. 50 l/min/subject in the present study). One reason for this difference might be that the earlier study measured the 18 O 3 concentration at a site distant from the breathing zone of the subjects so that surfaces for reaction with 18 O 3 within the exposure chamber could have reduced the actual concentrations inhaled. In the present study, 18 O 3 was measured in the breathing zone to better ensure that losses of 18 O 3 on surfaces would not occur. The in vitro exposures might also be affected by this phenomenon, however, there appeared to be fewer surfaces for reaction with 18 O 3 in the in vitro chambers than in the in vivo chambers. Another finding is that our earlier study employed dialysis of the BALF supernatant to separate the protein/lipid fraction from the NaCl present in the saline lavage-a necessity because high levels of NaCl can interfere with the 18 O assay.
The earlier reported 18 O levels in the dialyzed BALF high speed supernatant were higher than the present results found in the TCA-precipitated BALF high speed supernatant. It appears that TCA treatment may have dissociated the 18 O adduct, or failed to concentrate the same extracellular materials in BALF as did dialysis.
Limitations of the present study include the small number of in vitro replicate exposures as well as of human subjects contributing to the cultures. In addition, we observed significant intra-and inter-subject variations in 18 O in cells removed by brush biopsy. Part of this variation may be attributable to the fact that not all the inhaled ozone will react with the surface of airway epithelial cells that are then removed by brush biopsy. Some will react with compounds present in lung lining fluid such as mucin or antioxidants and these compounds may differ in concentration and among people or even in the same person on a day-to-day basis. This is also true to some extent within a subject. It is not known if mucin or antioxidants are distributed evenly throughout the airways. Another factor that may be contributing to variability is that airway cells are not a monolayer and there is a possibility that some of the cells not directly opening into the airway and therefore not receiving a dose of ozone (e.g., basal cells) would be removed during brush scraping to varying degrees from one individual to another or even from different locations within an individual. It is not known if the makeup of cell composition (e.g., % of ciliated cells, mucin secreting cells, clara cells, basal cells, etc.) is homogenous throughout the airway. Finally, some variability was probably due to the limited mass of sample that made it impossible to obtain more than one 18 O analysis for each bronchus sampled. Although the BALF cells sampled after in vivo exposure were obtained in a higher sample mass than the tissue mass of bronchial brush biopsies, we believe that the overall contribution of epithelial cells to the inflammatory response would be greater because of a larger surface area exposed to O 3 and a higher secretion of inflammatory cytokines in epithelial cells than other cells . Future studies should compare the sensitivity to injury of alveolar macrophages and epithelial cells and also determine the contribution of mucus or epithelial lining fluid covering the cells to the resulting dose and effect of O 3 . Another potential limitation is the possibility that the subjects studied had been exposed previously to ozone and as such might have experienced epigenetic effects that could alter the cell responses following in vitro ozone exposure. No attempt was made to control for this possibility because there are so many other outside influences that could also induce epigenetic effects, and because we presently have no evidence for this type of change in the scenario we have studied here. In summary, our results suggest that in vitro exposure conditions can be made to reasonably match the in vivo dose of O 3 to epithelial cells exposed in vivo and that comparable measures of dose and effect can be obtained. These studies add confidence to the possibility of extrapolating effects observed in vitro to effects that might occur in human airways in vivo.
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